ENTRY       D12267                      Drug
NAME        Romlusevimab (USAN)
FORMULA     C6354H9808N1676O202S40
EXACT_MASS  114111.7555
MOL_WEIGHT  114191.5713
SEQUENCE    (Heavy chain)
            QVQLVQSGSE LKKPGASVKV SCKASGYTFT TYVMNWVRQA PGQGLEWMGW INTNTGNPTY
            AQGFTGRFVF SLDTSVSTAS LQISSLKAED TAVYYCSSEI TTLGGMDVWG QGTTVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLYITREPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPG
            (Light chain)
            SYVLTQPPSV SVAPGKTARI TCGGNNIGSK SVHWYQQKPG QAPVLVIYYD SDRPSGIPER
            FSGSNSGNTA TLTISGVEAG DEADYYCQVW DSISDHRVFG GGTKLTVLGQ PKAAPSVTLF
            PPSSEELQAN KATLVCLISD FYPGAVTVAW KADSSPVKAG VETTTPSKQS NNKYAASSYL
            SLTPEQWKSH RSYSCQVTHE GSTVEKTVAP TECS
            (Disulfide bridge: H22-H96, H146-H202, H222-L213, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'213, H'263-H'323, H'369-H'427, L22-L87, L136-L195, L'22-L'87, L'136-L'195)
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of SARS-CoV-2 infection
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12267  Romlusevimab
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12267  Romlusevimab (USAN)
DBLINKS     CAS: 2509447-08-7
///
